Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

The University of Delhi has released a list of 6,100 <keyword id="21977691" type="General" weightage="20" keywordseo="vacant-seats" source="keywords">vacant seats</keyword> for the second round of undergraduate <keyword id="19962926" type="General" weightage="20" keywordseo="admissions" source="keywords">admissions</keyword>, following the conclusion of the first round. Vacant seats have been displayed on the dashboards of the candidates. With 91.98 per cent (65,843) of seats already filled, candidates have been provided the opportunity to re-order their (college and course) preferences from August 22 to 23. The university aims to begin the <keyword id="20248930" type="General" weightage="20" keywordseo="academic-session" source="keywords">academic session</keyword> on August 29. As many as 65,843 candidates have confirmed their admission to undergraduate courses at <keyword id="19927119" type="General" weightage="20" keywordseo="delhi-university" source="keywords">Delhi University</keyword> in the first round. The total number of <keyword id="22671029" type="General" weightage="20" keywordseo="undergraduate-seats" source="keywords">undergraduate seats</keyword> in <keyword id="21617246" type="General" weightage="20" keywordseo="DU-colleges" source="keywords">DU colleges</keyword> is around 71,600. Early this month, the university began the allocation acceptance process, offering 97,387 seats in the first round. To ensure optimal seat occupancy, the administration decided to make extra allocations, targeting an academic session starting on August 29. The university is conducting admissions for 71,600 seats (excluding supernumerary seats) in 69 colleges and departments. There are 1,559 programme-college combinations available for admissions. This year, DU has introduced a feature on the candidates' dashboard, enabling them to view the details of <keyword id="22889419" type="General" weightage="20" keywordseo="cutoffs-and-ranks" source="keywords">cutoffs and ranks</keyword> determining seat allocation based on category and quota. Earlier in the month, the University of Delhi (DU) climbed five spots to secure the 6th position in the National Institutional Ranking Framework (<keyword id="20051367" type="General" weightage="20" keywordseo="nirf" source="keywords">NIRF</keyword>) 2024. DU Vice Chancellor Professor Yogesh Singh attributed this achievement to the collective efforts of the university's faculty, students, and staff. In the university category at the national level, DU had previously moved up two spots to reach the 11th position last year. This year, the university continued its upward trajectory, also climbing seven places in the overall ranking to secure the 15th spot.

Delhi University admissions: Only 6,100 undergraduate seats up for grabs in Round 2

The national capital has reported an "isolated" case of Japanese Encephalitis, official sources said on Thursday. All public health measures have been instituted as per the National Centre for Vector Borne Diseases Control (NCVBDC) guidelines, the sources said, adding there was no cause for concern. Referring to an order issued by the Municipal Corporation of Delhi on Wednesday, the sources said that the 72-year-old man from west Delhi was admitted to the All India Institute of Medical Sciences on November 3 following chest pain. The patient was diabetic, had coronary artery disease, bilateral lower limb weakness and bowel and bladder incontinence, the source said. After the patient's blood sample was collected on November 6, he tested positive for Japanese Encephalitis. He was discharged on November 15, the sources said. According to the Integrated Disease Surveillance Programme data, in 2024, 1,548 Japanese Encephalitis cases were reported from 24 states and Union Territories, with 925 cases from Assam alone. The central government guidelines, two doses of the vaccine have been a part of the Universal Immunisation Programme since 2013. Adult <keyword id="24203625" type="General" weightage="20" keywordseo="Japanese-Encephalitis-vaccine" source="keywords">Japanese Encephalitis vaccine</keyword> has been introduced in high-burden states, sources said. "No outbreak of Japanese Encephalitis has been reported in Delhi in the past although occasional isolated cases have been reported from tertiary hospitals like AIIMS, Ram Manohar Lohia and Safdarjung among others - mostly from neighbouring states," a source said. While all public health measures have been instituted according to the NCVBDC guidelines, there is no cause for concern due to this isolated case of Japanese Encephalitis, the source said. The Japanese Encephalitis virus is normally carried by waterfowl and amplified in pigs from where it is accidentally transmitted to humans through the bite of infected culex mosquitoes. The infection may result in febrile illness and in a small proportion of cases cause neurological illness and may result in death, he said. There is no specific treatment for Japanese Encephalitis and there is no human-to-human transmission of the virus, the source said. SEE ALSO:<a href="https://www.businessinsider.in/business/auto/news/honda-activa-e-and-qc1-electric-scooters-unveiled-in-india-to-go-on-sale-in-2025/articleshow/115725242.cms" target="_self"></a> <a href="https://www.businessinsider.in/business/auto/news/honda-activa-e-and-qc1-electric-scooters-unveiled-in-india-to-go-on-sale-in-2025/articleshow/115725242.cms" target="_self">Honda Activa e and QC1 electric scooters unveiled in India, to go on sale in 2025</a><a href="https://www.businessinsider.in/tech/news/indias-pc-market-reaches-new-high-with-4-49-million-shipments-in-q3-2024/articleshow/115719599.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/news/indias-pc-market-reaches-new-high-with-4-49-million-shipments-in-q3-2024/articleshow/115719599.cms" target="_blank">India’s PC market reaches new high with 4.49 million shipments in Q3 2024</a><a href="https://www.businessinsider.in/tech/mobile/news/realme-gt-7-pro-with-snapdragon-8-elite-chipset-launched-starting-at-59999/articleshow/115689685.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/mobile/news/realme-gt-7-pro-with-snapdragon-8-elite-chipset-launched-starting-at-59999/articleshow/115689685.cms" target="_blank">Realme GT 7 Pro with Snapdragon 8 Elite chipset launched starting at ₹59,999</a>

Delhi reports 'isolated' case of Japanese Encephalitis

Doctors in India are grappling to diagnose and treat unexplained and persistent symptoms of <keyword id="9814327" type="General" weightage="100" keywordseo="long-covid" source="Orion">long Covid</keyword> patients due to limited guidelines, whereas researchers have flagged inadequate studies on the condition. With the <keyword id="19896311" type="General" weightage="20" keywordseo="world-health-organization" source="keywords">World Health Organization</keyword> declaring an end to <keyword id="19896627" type="General" weightage="20" keywordseo="covid" source="keywords">Covid</keyword> as a global <keyword id="416511" type="General" weightage="20" keywordseo="health-emergency" source="Orion">health emergency</keyword> in May last year, focused efforts are underway around the world to estimate the burden of long Covid among the population. The condition refers to the set of lingering symptoms affecting varied body parts and persisting well beyond the acute Covid infection period, including cough, muscle and joint pain, fatigue, brain fog and difficulty in focusing. The viral disease is caused by the SARS-CoV-2 virus. While studies have suggested that about a third of those moderately or severely infected are likely to suffer from long Covid, region-wise though, incidence could vary. A study by researchers, including those from <keyword id="19988007" type="General" weightage="20" keywordseo="harvard-medical-school" source="keywords">Harvard Medical School</keyword>, US, estimated that 31 % of the once-infected people in North America, 44% in Europe, and 51% in Asia, have long Covid, which is "challenging the healthcare system, but there are limited guidelines for its treatment". It was published in the International Journal of Infectious Diseases in September. In India, however, studies on long Covid are few and far between. One such study by Maulana Azad Medical College in New Delhi, conducted from May 2022 to March 2023 on 553 patients who had recovered from Covid, found that about 45% had lingering symptoms, persistent fatigue and dry cough being the most common. "There is limited exploratory research on the long Covid syndrome with scarce data on long-term outcomes," the authors wrote in the study published in the journal Cureus in May this year. Understanding the long-term effects of the virus is important for developing management strategies, optimising healthcare delivery, and providing support to recovered Covid patients in the community, they said. Dr Rajesh Sagar, Professor of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, said, "Looking at the current state of long Covid studies in India, it is too premature to say that we understand the condition well enough to know how to diagnose or treat it." Animesh Samanta, assistant professor at School of Natural Sciences in <keyword id="19897094" type="General" weightage="20" keywordseo="shiv-nadar-university" source="keywords">Shiv Nadar University</keyword>, Greater Noida, said, "While studies in India highlight the growing recognition of neurological complications in long Covid patients, more focused research on neuroinflammation is needed." Doctors, too, have reported a rise in patients complaining of symptoms that they did not have pre-Covid. "People who never had <keyword id="6465125" type="General" weightage="20" keywordseo="asthma" source="Orion">asthma</keyword> in the past, post-Covid, with every viral infection, they get a long cough, shortness of breath and wheezing, which require the use of <keyword id="31257" type="General" weightage="20" keywordseo="inhalers" source="Orion">inhalers</keyword> or nebuliser," senior consultant Dr Neetu Jain, who runs a post-Covid care clinic at Pushpawati Singhania Hospital and Research Institute, New Delhi, said. Dr Arun Garg, chairman, Neurology and Neurosciences, Medanta-The Medicity, Gurugram, said he was noticing a spike in stroke cases among young patients not suffering from known risk factors such as diabetes, hypertension and obesity. "Similarly, we are seeing more cases of encephalopathy (swelling of the brain) without reason and having a confused state of mind following one or two days of fever. Their MRI scans show no changes. These patients have increased significantly after Covid," he said. In the absence of medical guidelines to diagnose long Covid, doctors are having to resort to broad, non-specific tests and questionnaires to gauge a patient's 'quality of life'. Studies have shown that the fatigue experienced in long Covid is similar to that in cancer patients, with a quality of life similar to patients of Parkinson's disease. "We really do not have any test to diagnose long Covid, even though it is definitely a clinical diagnosis. We diagnose long Covid for people who had at least moderate to severe infection, following which they could never regain the quality of life pre-Covid. Checking for inflammatory markers like C-reactive proteins (CRP) can support the diagnosis," Dr Jain said. "Other than routine blood tests that measure inflammation, we do antibody tests to look for direct markers. In many of these patients, we are finding rare antibodies which are very new to us and were not there pre-Covid," Dr Garg said. Inflammation persisting despite recovery from acute Covid infection is thought to lie at the heart of long Covid. However, tests to measure this specific immune response are lacking, even as researchers have been working in this direction worldwide. One such effort comes from Shiv Nadar University, where a team led by Samanta has developed a fluorescent probe capable of detecting inflammation in brain cells that can arise due to Covid infection. The probe measures nitric oxide levels in brain cells, especially in human microglia cells, where increased NO levels are linked to the SARS-CoV-2 infection. Microglia are immune cells in the brain that fight disease and help maintain brain health. Lysosomes within microglia, which help clear foreign disease-causing agents like the SARS-CoV-2 virus, produce nitric oxide as part of an immune response to infection. The probe detects nitric oxide produced in lysosomes in response to infection and thereby allows for a measurement of inflammation levels. This examination method can provide "qualitative information on infection status", said Samanta, corresponding author on the study published in the journal Analytical Chemistry in American Chemical Society. He explained that patients with pre-existing conditions such as Alzheimer's disease, Parkinson's disease or multiple sclerosis (an autoimmune disorder) could exhibit prolonged neuroinflammation and loss of brain cells following Covid infection. While the probe has shown efficacy in cell cultures, animal studies would need to be done, before testing it in humans, Samanta said. Looking at the World Health Organization International Clinical Trials Registry Platform, the study by Harvard Medical School had found that 587 clinical studies were conducted on long Covid, of which about 53% (312) were testing potential treatments. Most of these were found to be conducted in the US (58), followed by India (55) and Spain (20). The trials looked at interventions including physical exercise, psychotherapy, and pharmacological ones such as paxlovid and fluvoxamine. However, "to date, only 11 of these 312 studies have published their results that were not confirmative," the researchers wrote. The team called for studies to look into sleep disorders which were rarely included in the registered clinical studies. Further, interventions targeting the biological processes responsible for long Covid are needed but currently lacking, they said.

Doctors struggle to treat long Covid patients in India; researchers point to inadequate studies

The <keyword id="22407175" type="General" weightage="100" keywordseo="U-WIN" source="keywords">U-WIN</keyword> portal, a replication of the <keyword id="19897423" type="General" weightage="20" keywordseo="COVID-19" source="keywords">Covid-19</keyword> vaccine management system Co-WIN, is set for a pan-India launch likely by the end of August, aiming to maintain an electronic registry of routine immunisations, official sources said. Currently, U-WIN is in pilot mode across all states and Union Territories, except for West Bengal, which is yet to start uploading data, the sources told PTI, adding that it is still under consideration in the state. The U-WIN platform captures every <keyword id="19933690" type="General" weightage="20" keywordseo="vaccination" source="keywords">vaccination</keyword> event for pregnant women and children under the Universal Immunization Programme (UIP). Minister of Finance <keyword id="19916618" type="General" weightage="20" keywordseo="nirmala-sitharaman" source="keywords">Nirmala Sitharaman</keyword> had announced in the interim Budget for 2024-2025 that U-WIN, along with intensified efforts under Mission Indradhanush, will be rolled out nationwide for managing <keyword id="21423640" type="General" weightage="20" keywordseo="immunisation" source="keywords">immunisation</keyword>. "The U-WIN will ensure timely administration of vaccine doses by digitally recording every vaccination event under the Universal Immunisation Programme among all pregnant women and children aged 0-5 years," an official told PTI. "The portal will target 2.9 crore pregnant women and 2.6 crore infants (0-1 years) annually by providing 11 vaccines against 12 vaccine preventable diseases -- diphtheria, measles, rubella, and tetanus through more than 1.2 crore vaccination sessions across the country," the official added. The platform generates a uniform QR-based, digitally verifiable e-vaccination certificate, similar to Covid vaccination certificate, which can be accessed anytime by the citizens through a single click. Vaccination records under UIP are being maintained manually as of now. So this will do away with the hassle of keeping a physical record, the officials explained. It will enable the digitisation of session planning, and updating vaccination status on a real-time basis, they added. "Also, there is no mechanism of individual tracking. There is also lack of awareness among beneficiaries about session location and date especially in urban areas and iniquity in immunisation coverage in states and UTs," another official said. "Besides, another major issue is that immunisation at private health facilities is not recorded," the official added. The U-WIN is going to be the single source of information for immunisation services which will record pregnancy details and outcome, newborn registration and immunisation at birth. It will update vaccination status, and delivery outcome, among others, on real time, the official said. As of July 9, 2024, the pilot has registered 5.33 crore beneficiaries on U-WIN. Over 83.55 lakh vaccination sessions have been digitally conducted, and 18.15 crore vaccine doses have been recorded. The platform aims to reduce zero-dose and left-out children through a name-based tracking mechanism and empower citizens with anytime, anywhere access to vaccination services, particularly benefiting migratory populations, the official said. "The U-WIN portal is likely to be launched pan <keyword id="19895063" type="General" weightage="20" keywordseo="India" source="keywords">India</keyword> in August end," the official stated. Citizens can self-register for vaccinations via the U-WIN web portal or its Android mobile application, select preferred vaccination centres, and schedule appointments. Automated SMS alerts inform citizens about registration confirmations, administered doses, and upcoming dose reminders, ensuring timely and age-appropriate vaccinations. It also facilitates the creation of Ayushman Bharat Health Account (ABHA) IDs for comprehensive health record maintenance. The U-WIN also supports the frontline workers to digitally record all vaccination events for children and pregnant women for complete, accurate and easy record maintenance, the official said.

Pan-India rollout of U-WIN to track routine immunisations likely by Aug end

Have you ever considered that your regular commute to and fro work could potentially shave off some years from your life? And no, we’re not talking about road traffic accidents but the slow poison we’re inhaling unbeknownst to us: air pollutants. A new study published in <a href="https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(24)00114-1/fulltext">The Lancet Planetary Health</a> by an international team of researchers reveals a terrifying truth: over 7% of daily deaths in 10 major <keyword id="20026638" type="General" weightage="20" keywordseo="Indian-cities" source="keywords">Indian cities</keyword> are attributed to <keyword id="19900550" type="General" weightage="20" keywordseo="air-pollution" source="keywords">air pollution</keyword> caused by <keyword id="22110704" type="General" weightage="20" keywordseo="PM2-5-pollutants" source="keywords">PM2.5 pollutants</keyword> exceeding the World Health Organization's (WHO) safe limits. These PM2.5 pollutants are microscopic particles, 2.5 micrometres or less in diameter, that come from <keyword id="2839914" type="General" weightage="20" keywordseo="vehicle-emissions" source="Orion">vehicle emissions</keyword> and industrial activities. Imagine tiny daggers — that's what these PM2.5 particles are like, infiltrating deep into lungs and even the bloodstream, wreaking havoc on our health. The study found that PM2.5 levels breach WHO guidelines a staggering 99.8% of the time in these cities. The analysis covered major cities like Delhi, Mumbai, Bengaluru, Ahmedabad, Chennai, Hyderabad, Kolkata, Pune, Shimla and Varanasi. A staggering 7.2% of deaths in these cities, translating to roughly 33,000 annually, were associated with short-term PM2.5 levels exceeding the WHO's recommended limit (15 micrograms per cubic metre) between 2008 and 2019. Delhi, unfortunately, takes the crown for the most polluted. A shocking 11.5% of its annual deaths are attributed to air pollution, translating to a devastating 12,000 lives lost each year. The link between PM2.5 and mortality is undeniable. Researchers found that a mere 10 microgram per cubic metre increase in these pollutants correlates with a 1.4% rise in daily deaths. This risk factor doubles when considering only levels below India's air quality standards, which are, worryingly, less strict than the WHO's recommendations. But here's a surprising twist: the association between PM2.5 and death is even stronger in cities with generally cleaner air, like Bengaluru and Chennai. This suggests that locally produced pollutants, from sources like construction dust or waste burning, might be significant contributors. There is a glimmer of hope, however. The study emphasises that implementing stricter air quality standards and utilising proven pollution control methods from other parts of the world can be game changers. Lowering and enforcing stricter air quality limits will save tens of thousands of lives per year, emphasises Joel Schwartz, a co-author from Harvard University. This study serves as a stark wake-up call. The air we breathe in many Indian cities is a gamble, with every breath potentially harmful. Taking decisive action to curb pollution is not just about a cleaner environment, it's about saving the lives of millions of Indians.

Air pollution kills thousands in Indian cities like Delhi, Mumbai, Bengaluru, Kolkata every year: Lancet study

IIT Madras tops Indian institute ranking fifth year in a row – here are the top 10

New Delhi, Artificial intelligence (AI) can help recognise individuals with anxiety disorders based on their unique brain structure, according to a study. The research, published in the journal <keyword id="21011394" type="General" weightage="20" keywordseo="nature-mental-health" source="keywords">Nature Mental Health</keyword>, involved about 3,500 youth between 10 and 25 years old from across the globe. The researchers used machine learning (ML) -- a type of AI that help machines learn and improve from data analysis without explicit programming -- looked at cortical thickness and surface area, along with volumes of deep-lying brain regions. To improve the results, the algorithms must be further refined and other types of brain data, such as brain function and connections, must be added, they said. These initial results tend to hold -- are generalisable -- in such a diverse group of youngsters in terms of ethnicity, geographical location and clinical characteristics, the researchers said. This renders the study outcomes rather fascinating, they said. According to lead researcher <keyword id="21011392" type="General" weightage="20" keywordseo="moji-aghajani" source="keywords">Moji Aghajani</keyword>, Assistant Professor at <keyword id="21011393" type="General" weightage="20" keywordseo="leiden-university" source="keywords">Leiden University</keyword> in <keyword id="19961720" type="General" weightage="20" keywordseo="netherlands" source="keywords">Netherlands</keyword>, the study could eventually facilitate a more personalised approach to prevention, diagnostics and care. Anxiety disorders typically first emerge during adolescence and early adulthood. These disorders cause major emotional, social and economic problems for millions of youngsters worldwide. However, it is unclear which brain processes are involved in these anxiety disorders, the researchers said. "This incomplete understanding of underlying brain bases is largely due to our simplistic approach to mental disorders among youths, in which clinical studies are often too small in size, with way too much focus on the 'average patient' rather than the individual," said <keyword id="21011395" type="General" weightage="20" keywordseo="aghajani" source="keywords">Aghajani</keyword>. "This, moreover, concurs with use of traditional analytical techniques, which are unable to produce individual-level outcomes," the researcher added. However, the field is slowly changing, with more focus on individuals and their unique brain characteristics, through the use of large and diverse datasets -- also known as "big data" -- combined with AI.

AI can identify clinically anxious youth based on brain structure: Study

New Delhi, People who sleep for only three to five hours daily may be at a higher risk of developing type 2 diabetes, according to a study. The research, published in the journal <keyword id="20272108" type="General" weightage="20" keywordseo="jama-network-open" source="keywords">JAMA Network Open</keyword>, also shows that chronic sleep deprivation cannot be compensated by healthy eating alone. "I generally recommend prioritising sleep, although I understand it's not always possible, especially as a parent of four teenagers," said <keyword id="20852361" type="General" weightage="20" keywordseo="christian-benedict" source="keywords">Christian Benedict</keyword>, Associate Professor at <keyword id="20307239" type="General" weightage="20" keywordseo="uppsala-university" source="keywords">Uppsala University</keyword> and lead researcher behind the study. The team examined the link between type 2 diabetes and sleep deprivation. Type 2 diabetes affects the body's ability to process sugar (glucose), hindering insulin absorption and resulting in high blood sugar levels. A 2020 study showed that over 462 million people suffer from this disease. Over time, it can cause serious damage, particularly to nerves and blood vessels, and thus represents an escalating public health problem globally. "Previous research has shown that repeated short daily rest increases the risk of type 2 diabetes, while healthy dietary habits such as regularly eating fruit and vegetables can reduce the risk," said <keyword id="20852360" type="General" weightage="20" keywordseo="diana-noga" source="keywords">Diana Noga</keyword>, a sleep researcher at the Department of Pharmaceutical Biosciences at Uppsala University. "However, it has remained unclear whether people who sleep too little can reduce their risk of developing type 2 diabetes by eating healthily," <keyword id="20852359" type="General" weightage="20" keywordseo="noga" source="keywords">Noga</keyword> said in a statement. The researchers used data from one of the largest population databases in the world, the UK Biobank, in which nearly half a million participants from the UK have been genetically mapped and responded to questions on health and lifestyle. They followed the participants for over 10 years and found that a sleep duration of between three and five hours was linked to a higher risk of developing type 2 diabetes. In contrast, healthy eating habits led to a lower risk of developing the disease, but even people who ate healthily but slept less than six hours a day were still at higher risk of type 2 diabetes. "Our results are the first to question whether a healthy diet can compensate for lack of sleep in terms of the risk of type 2 diabetes. They should not cause concern, but instead be seen as a reminder that sleep plays an important role in health," Benedict added.

Sleeping for just 3-5 hours daily may increase type 2 diabetes risk: Study

SpiceJet's Chairman &amp; Managing Director <keyword id="6357826" type="General" weightage="80" keywordseo="ajay-singh" source="Orion">Ajay Singh</keyword> has assumed charge as the President <keyword id="6355988" type="General" weightage="100" keywordseo="assocham" source="Orion">Assocham</keyword>, replacing Renew Power MD Sumant Sinha after the completion of his tenure. <keyword id="6379795" type="General" weightage="50" keywordseo="sanjay-nayar" source="Orion">Sanjay Nayar</keyword>, founder and Chairman of Sorin Investment Fund is the new Senior Vice-President of Assocham, the industry body said in a release on Wednesday. "I am taking over at times which are both exciting and challenging. As an economy, India stands out as a robust economy in the midst of global headwinds. Even when major economies of the world are facing the threat of recession, the Indian economy is growing between 6.5-7 per cent," Singh said. He emphasised that the chamber would stay engaged with the government, Centre and states, leading academicians, economists besides corporate leaders to find solutions to the issues, which may crop up in a fast-changing global economic and political landscape. Singh studied at the Indian Institute of Technology - Delhi, where he received a degree in engineering, and got his Master's degree in Business Administration from Cornell University in the US. He also holds a Bachelor's degree in <keyword id="6355470" type="General" weightage="80" keywordseo="law" source="Orion">Law</keyword> (LLB) from the Law Faculty, the <keyword id="151282" type="General" weightage="50" keywordseo="university-of-delhi" source="Orion">University of Delhi</keyword>. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/news/net-office-leasing-drops-34-in-jan-mar-to-six-quarter-low-across-top-7-cities-jll-india/articleshow/99115015.cms">Net office leasing drops 34% in Jan-Mar to six-quarter low across top 7 cities: JLL India</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/finance/news/sebi-directs-top-100-listed-firms-to-clarify-market-rumours-from-oct-1/articleshow/99115234.cms">SEBI directs top 100 listed firms to clarify market rumours from Oct 1</a>

You Searched For "the delhi university" and got 9 results

Delhi University admissions: Only 6,100 undergraduate seats up for grabs in Round 2

ANI

Delhi reports 'isolated' case of Japanese Encephalitis

PTI

Doctors struggle to treat long Covid patients in India; researchers point to inadequate studies

Business Insider India

Pan-India rollout of U-WIN to track routine immunisations likely by Aug end

PTI

Air pollution kills thousands in Indian cities like Delhi, Mumbai, Bengaluru, Kolkata every year: Lancet study

Ashmita Gupta

IIT Madras tops Indian institute ranking fifth year in a row – here are the top 10

Sourabh Jain

AI can identify clinically anxious youth based on brain structure: Study

PTI

Sleeping for just 3-5 hours daily may increase type 2 diabetes risk: Study

PTI

SpiceJet CMD Ajay Singh takes over as the president of industry body Assocham

PTI

Popular Keywords

Buying Guides